Global University Venturing

Duke University’s OLV managed a near-50% increase on 2017’s spinout tally in a year where its businesses generated $526m in capital.

Karolinska Development has celebrated an exit as Umeå spinout Asarina Pharma went public in Sweden after raising $16.3m in its initial public offering.

Lettus Grow, an irrigation system provider from University of Bristol and SetSquared's ecosystem, has been backed by the university's Enterprise Fund.

David Broecker has become PRF’s chief innovation and collaboration officer, bringing with him expertise from the biosciences and philanthropic funding agency IBRI.

A roundup of all the week's news on Global University Venturing for our subscribers.

Technion’s robotic surgery business Mazor Robotics has been snapped up by medical device developer Medtronic, which had already invested $72m in the company.

Bristol microscopy technology spinout NuNano has secured cash from the university’s Enterprise Fund for a second time.

Stanford-StartX Fund is among medical device developer Madorra’s backers, along with Fogarty Institute of Innovation and OneVentures Healthcare.

The Parkwalk-managed University of Bristol Enterprise Fund has joined parent IP Group to become an investor in macular degeneration-focused spinout Exonate.

Immune-Onc, an immuno-oncology therapy developer exploiting University of Texas research, has received more than $33m from investors including Stanford-StartX fund.

Nationwide Children’s Hospital spinout Celenex could fetch as much as $452m upon completion of milestones after progressing rare disease therapies conceived at the hospital’s collaborative program with Ohio State University.